Fairchem Organics Limited has seen a significant reduction in stake by 360ONE Portfolio Managers Limited, according to a recent regulatory filing. The portfolio management firm sold 4,21,570 shares, representing a 3.24% stake in the company, through open market transactions on November 21, 2025.

Transaction Details

This substantial reduction in shareholding triggered regulatory disclosure requirements under the Securities and Exchange Board of India (SEBI) takeover regulations. The regulations mandate disclosure when there is a change in shareholding exceeding 2% of the total shareholding in a target company.

Regulatory Compliance

The disposal was executed in compliance with Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. This regulation requires any entity, along with persons acting in concert, to disclose changes in shareholding or voting rights if:

1. They hold 5% or more of the shares or voting rights in a target company.
2. There is a change in such holdings from the last disclosure made.
3. The change exceeds 2% of total shareholding or voting rights in the target company.

Market Impact

While the specific reasons for 360ONE Portfolio Managers' decision to reduce its stake were not disclosed, such significant changes in institutional holdings often attract market attention. Investors and analysts may closely monitor this development for potential impacts on Fairchem Organics' stock price and trading patterns.

About Fairchem Organics

Fairchem Organics Limited is listed on both the BSE Limited and NSE Limited. As per the latest filing, the company's total equity share capital stands at 1,30,20,902 shares.

This stake reduction by a prominent portfolio management firm may prompt other investors to reassess their positions in Fairchem Organics. However, it's important to note that investment decisions should be based on comprehensive analysis and not solely on the actions of other market participants.

Fairchem Organics Limited, a key player in the Indian chemical industry, has announced that its Board of Directors will convene on November 20, 2025, to discuss a potential share buyback program. This move could significantly impact the company's capital structure and shareholder value.

Key Details of the Announcement

Potential Implications

A share buyback, if approved, could have several implications for Fairchem Organics and its shareholders:

1. Enhanced Shareholder Value: Buybacks typically aim to increase the value of remaining shares by reducing the total number of outstanding shares.

2. Capital Structure Optimization: The company may be looking to optimize its capital structure through this potential buyback.

3. Market Signal: Such a move might be interpreted as a signal of the company's confidence in its financial health and future prospects.

Regulatory Compliance

Fairchem Organics has emphasized its commitment to regulatory compliance throughout this process:

• The meeting announcement adheres to Regulation 29(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
• The company has stated that it will disseminate the outcome of the Board meeting to the Stock Exchanges promptly after its conclusion.

Investor Advisory

Shareholders and potential investors should note that this announcement is not a confirmation of a buyback but rather an indication that the proposal will be discussed. The final decision will be made public following the Board meeting.

Interested parties can find more information on the company's website at www.fairchem.in .